Newell A. Jeffrey - 30 Dec 2022 Form 4 Insider Report for TRxADE HEALTH, INC (SCNX)

Role: Director
Signature: /s/ Newell A. Jeffrey
Issuer symbol: SCNX
Transactions as of: 30 Dec 2022
Net transactions value: $0
Form type: 4
Filing time: 30 Dec 2022, 18:50:52 UTC
Previous filing: 14 Oct 2022
SEC: View on sec.gov

Quoteable Key Fact

"Newell A. Jeffrey filed Form 4 for TRxADE HEALTH, INC (SCNX) on 30 Dec 2022."

Quick Takeaways

This page summarizes Newell A. Jeffrey's Form 4 filing for TRxADE HEALTH, INC (SCNX).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 30 Dec 2022, 18:50.

What Changed

Previous filing in this sequence was filed on 14 Oct 2022.
Current net transaction value: $0.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MEDS	Common stock	Award	$0	+79,062		$0.000000	79,062	30 Dec 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/2 of the shares on January 1, 2023 and April 1, 2023, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d).
F2	Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors.

Content

Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/2 of the shares on January 1, 2023 and April 1, 2023, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d).

Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors.